Literature DB >> 19457979

Structural insight into the binding mode between the targeting domain of ALE-1 (92AA) and pentaglycine of peptidoglycan.

Hideki Hirakawa1, Hidenori Akita, Tamaki Fujiwara, Motoyuki Sugai, Satoru Kuhara.   

Abstract

ALE-1 is a glycylglycine endopeptidase that selectively targets and lyses Staphylococcus aureus, and is expected to be a next generation antibacterial agent because of its substrate specificity to pathogenic bacteria. It has a central catalytic domain and a targeting domain called 92AA. 92AA has been shown to recognize pentaglycine, but the molecular mechanism by which it recognizes and interacts with pentaglycine has not been elucidated. To predict the binding modes of pentaglycine is important for estimating the catalytic reaction mechanism of ALE-1. In the present study, we characterized the binding cleft of 92AA by a computational method and modeled the complexes formed between 92AA and the pentaglycine of peptidoglycan by a binding simulation. In addition, we performed precise simulations of the molecular dynamics by which the complexes identify the amino acid residues interacting with the pentaglycine. We also experimentally constructed mutants in which the amino acid residues present in the binding cleft were changed by site-directed mutagenesis and assessed their ability to bind to peptidoglycan by ELISA. Based on the results of these analyses, we proposed a mode of binding between 92AA and the pentaglycine of peptidoglycan, and modeled the energetically stable complexes between 92AA and the pentaglycine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457979     DOI: 10.1093/protein/gzp014

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  6 in total

1.  Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells.

Authors:  Hideaki Yamaguchi; Tao Yu; Toshiro Noshita; Yumi Kidachi; Katsuyoshi Kamiie; Kenji Yoshida; Tatsuo Akitaya; Hironori Umetsu; Kazuo Ryoyama
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.

Authors:  Hai-Rong Lu; Mei-Gang Gu; Qiang Huang; Jin-jiang Huang; Wan-Ying Lu; Hong Lu; Qing-Shan Huang
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

3.  Structural bases of peptidoglycan recognition by lysostaphin SH3b domain.

Authors:  Paweł Mitkowski; Elżbieta Jagielska; Elżbieta Nowak; Janusz M Bujnicki; Filip Stefaniak; Dorota Niedziałek; Matthias Bochtler; Izabela Sabała
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

4.  Structural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysin.

Authors:  Jingmin Gu; Yingang Feng; Xin Feng; Changjiang Sun; Liancheng Lei; Wei Ding; Fengfeng Niu; Lianying Jiao; Mei Yang; Yue Li; Xiaohe Liu; Jun Song; Ziyin Cui; Dong Han; Chongtao Du; Yongjun Yang; Songying Ouyang; Zhi-Jie Liu; Wenyu Han
Journal:  PLoS Pathog       Date:  2014-05-15       Impact factor: 6.823

5.  Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans.

Authors:  Izabela Sabala; Elzbieta Jagielska; Philip T Bardelang; Honorata Czapinska; Sven O Dahms; Jason A Sharpe; Richard James; Manuel E Than; Neil R Thomas; Matthias Bochtler
Journal:  FEBS J       Date:  2014-08-01       Impact factor: 5.542

6.  Structural and Functional Insights Into Lysostaphin-Substrate Interaction.

Authors:  Helena Tossavainen; Vytas Raulinaitis; Linda Kauppinen; Ulla Pentikäinen; Hannu Maaheimo; Perttu Permi
Journal:  Front Mol Biosci       Date:  2018-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.